跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BZK TOWELETTE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BZK TOWELETTE
Authorized
STANDARD
BZK TOWELETTE
innovation line inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5d7a730ff0ead4a3
Company
innovation line inc
Type
Standard
Approval Details
Approval Id
5d7a730ff0ead4a3
Drug Approval Canada Name
BZK TOWELETTE
Product Name
BZK TOWELETTE
Status
Cancelled (Unreturned Annual)
Status Date
2023-01-09
Original Market Date
2016-03-01
Din
02448882
Drug Class
Human
Dosage Form
Wipe
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:04.92
Atc Original
D08AJ01 BENZALKONIUM
Atc Name
d 08 aj 01
Aig Number
0104993021
Company Name
innovation line inc
Company Address
11869 Teale Street, Culver City, California, United States, 90230
Active Ingredients
BENZALKONIUM CHLORIDE
0.133 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5d7a730ff0ead4a3
Type
Standard
Back to Health Canada Approvals